Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07823101 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis

StatusRecruiting
PhaseNot specified
Started2026-10
View on ClinicalTrials.gov ↗
384 trials monitored
See 17 trials at risk
This study will evaluate whether neuromuscular ultrasound and MRI can be used as imaging markers of bulbar involvement and swallowing dysfunction in individuals with inclusion body myositis (IBM). Researchers will compare imaging and clinical findings in participants with IBM with those in participants with other myopathies, ALS, PLS, and healthy volunteers. The study is a one-time visit. Study procedures may include neurological assessments, swallowing questionnaires, tongue strength testing, neuromuscular ultrasound, and MRI. The goal is to identify more sensitive and objective ways to assess bulbar dysfunction biomarkers.
Trial Details
NCT Number NCT07823101
Lead Sponsor Johns Hopkins University
Conditions IBM, Inclusion Body Myositis, Myopathy, Myositis, ALS (Amyotrophic Lateral Sclerosis), PLS
Enrollment 30 participants
Start Date 2026-10
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-16